Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis

Georgios Makragiannis, Kaveh Vahdani, Ester Carreño*, Richard W.J. Lee, Andrew D. Dick, Adam H. Ross

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)

2 Citations (Scopus)
250 Downloads (Pure)

Fingerprint Dive into the research topics of 'Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis'. Together they form a unique fingerprint.

Medicine & Life Sciences